GoodRx Holdings Inc
GDRX
NASDAQ
Health Care
$3.72
USD
-0.01 (-0.27%)
At close: Aug 17, 2026, 4:00 PM EDT
Market Cap $1.27B
Volume 1.3M
Revenue
$785.23M
TTM
-1.8%
YoY
Gross Margin
91%
TTM
-3.0%
YoY
Net Income
$16.25M
TTM
-53.0%
YoY
Operating Cash Flow
$201.58M
TTM
+5.8%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 203.1 | 196.0 | 194.8 | 194.0 | 200.4 |
YoY Growth | +1.2% | +0.4% | -1.9% | -4.4% | -1.3% |
Cost of Revenue | 13.4 | 13.4 | 17.5 | 20.2 | 21.0 |
Gross Profit | 189.7 | 182.6 | 177.3 | 173.9 | 179.4 |
Selling, General & Administrative | 113.2 | 115.5 | 102.6 | 107.9 | 106.8 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 162.9 | 168.0 | 154.6 | 159.8 | 155.8 |
Operating Income | 26.8 | 14.6 | 22.7 | 14.0 | 23.6 |
EBITDA | 46.5 | 36.1 | 45.8 | 35.8 | 45.9 |
Other Income / Expense | 0.7 | 0.0 | 0.0 | 0.0 | 0.6 |
Total Other Income / Expense | -7.2 | -8.5 | -8.5 | -8.4 | -8.2 |
Income Before Income Taxes | 19.6 | 6.1 | 14.2 | 5.6 | 15.5 |
Income Taxes | 6.7 | 5.0 | 8.8 | 4.5 | 6.9 |
Net Income | 12.8 | 1.1 | 5.4 | 1.2 | 8.5 |
Consolidated Net Income / Loss | 12.8 | 1.1 | 5.4 | 1.2 | 8.5 |
Net Income Attributable to Common Shareholders | 12.8 | 1.1 | 5.4 | 1.2 | 8.5 |
Basic EPS | $0.04 | $0.00 | $0.02 | $0.00 | $0.03 |
Diluted EPS | $0.04 | $0.00 | $0.02 | $0.00 | $0.02 |
Basic Shares Outstanding | 356.6M | 346.8M | 342.7M | 340.5M | 339.3M |
Diluted Shares Outstanding | 357.2M | 347.8M | 343.3M | 341.4M | 348.1M |